
Aruna Irani's battle with breast cancer and the question of chemotherapy
Veteran actress Aruna Irani recently surprised fans by revealing that she quietly battled breast cancer not once, but twice.Irani first discovered she had breast cancer in 2015, after feeling unwell on a shoot. 'I don't know how, but I felt something,' she recalled. A doctor initially brushed it off as a small lump, but Irani insisted on having it removed. When advised to take chemotherapy, she declined.advertisementShe said, "The doctor told me that I have to undergo chemotherapy clinically. Chemotherapy wasn't that advanced back then. So your skin turned black, and you would experience hair loss. I asked the doctor for another way, and he told me to take medicine daily. That went on for five years."
Chemotherapy is a type of cancer treatment that uses strong medicines to kill fast-growing cancer cells in the body. It can be given as pills or through injections. While it kills cancer cells, it can also affect healthy cells, which may cause side effects like hair loss, tiredness, or nausea.Her decision, however, came with consequences.In March 2020, just before the Covid-19 pandemic, her cancer returned. This time, Irani followed the medical advice and underwent chemotherapy. 'It was my fault because I did not opt for chemotherapy the first time. This time around, I took it,' she said.
Chemotherapy uses strong medicines to kill cancer cells in the body. ()
advertisementHer story, shared in an interview with Lehren Retro podcast, opens up an important health conversation: can some cancers be treated without chemotherapy?WHEN IS CHEMOTHERAPY AVOIDABLE?Irani's journey is not unique. With advances in precision oncology, many patients today have the option of skipping chemotherapy, depending on the type and stage of their cancer.'Definitely not all breast cancers require chemotherapy,' Dr. Mandeep Singh Malhotra, founder of the Art of Healing Cancer Centre told IndiaToday.in. 'Breast cancer is a heterogeneous group, with multiple varieties.'Hormone-positive breast cancers, which make up 40–50% of breast cancer cases in India, are often driven by hormones like estrogen and progesterone.For these, hormone therapy (like anti-estrogen pills) can be an effective treatment, especially in early-stage cases where the cancer hasn't spread.'In such cases, we can run genomic tests to assess the risk of recurrence. If the cancer is low-risk, chemotherapy can often be avoided. These patients can be treated with surgery and hormone therapy alone, which helps them maintain a good quality of life," Dr. Malhotra explained.THE IMPORTANCE OF PERSONALISATIONDr. Saphalta Baghmar, Program Head for Breast Cancer at Amrita Hospital, Faridabad, agreed that the era of "one-size-fits-all" treatment is over.'Thanks to molecular diagnostics, we now know breast cancer is a spectrum of subtypes. Chemotherapy is required in aggressive types like triple-negative or HER2-positive cancers, but for hormone receptor-positive cancers, we can often safely skip it, especially when genomic tests show low recurrence scores,' she told IndiaToday.in.
If detected early, many hormone-driven breast cancers can be treated without chemotherapy. ()
Tests like Oncotype DX and MammaPrint help oncologists evaluate whether a patient can avoid chemo without compromising the treatment's effectiveness.IS RECURRENCE POSSIBLE?However, doctors warned that even with these treatments, recurrence is still a risk.'Yes, breast cancer can come back, whether or not chemotherapy was used. Recurrence depends on how advanced the cancer was at diagnosis, its biology, and how the patient responded to initial treatment. That's why follow-up is so critical," Dr. Baghmar said.As more women face breast cancer diagnoses, especially in India where rates are steadily rising, understanding whether chemotherapy is necessary is becoming an important part of the conversation."Today, beating cancer isn't just about surviving. It's about surviving well, and science is helping us do just that," Dr. Baghmar said.If detected early, many hormone-driven breast cancers can be treated without chemotherapy. But personalised care, regular monitoring, and awareness are essential for long-term survival.Must Watch

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
29 minutes ago
- Time of India
Maharashtra reports 61 new COVID-19 cases
Maharashtra recorded 61 new COVID-19 cases on Wednesday, taking the total of cases since January to 2,169, the health department said. New cases included 19 infections detected in Mumbai, three in Thane Municipal Corporation limits, two in Navi Mumbai, one in Mira Bhayandar, two in Panvel, one in Pune district, 11 in Pune city, five in Pimpri Chhinchwad, one in Satara district, one in Sangli district, three in Sangli city, two in Chhatrapati Sambhajinagar city, one in Nagpur district, seven in Nagpur city and two in Wardha. The health department has conducted 23,241 COVID-19 tests since January, it said, adding that as of now 1,695 patients have recovered. Mumbai has recorded 899 COVID-19 cases since the beginning of the year, including 435 in May and 458 in June so far. No death of a COVID-19 patient has been reported since Tuesday, the health department said. Live Events Since January 1, a total of 31 patients have died, out of which 30 had comorbidities and one was suffering from another disease.


Hans India
an hour ago
- Hans India
Infections due to new Covid strains not severe, we're monitoring: ICMR-NIV Director
Pune: The JN.1.16 sub lineage of Omicron variant and the XFG (LF.7 and LP.81.2) recombinant variant did not cause much severe Covid infection, said Dr Naveen Kumar, Director ICMR-National Institute of Virology (NIV) on Wednesday, even as the active number of cases declined after rising for over a month. According to the Health Ministry's latest update, there are 6,483 active cases and 113 deaths. This comes after the recent increase in Covid cases noticed since the second week of April, with active cases rising over 7,000 in the country. "Genomic analysis revealed that the surge was due to JN.1.16 sub lineage of omicron variant and since May 2025, it was replaced by the XFG (LF.7 and LP.81.2) recombinant variant," Kumar told IANS here. "The observations made as of now suggest that the disease associated with these strains are not very much severe," he added. He stated that since the beginning of the Covid-19 pandemic, the NIV has been tracking the virus and its different variants from its 73 Virus Research and Diagnostic Laboratory (VDRLs) across the country. "ICMR-NIV in Pune is continuously monitoring the evolution of SARS-CoV-2 by the whole genome sequencing of RT PCR positive samples referred from 73 VRDLs across the country. Covid has never gone ever since, you know, since 2019. NIV is closely monitoring the various strains circulating in the country," Kumar told IANS. India has submitted the whole genome sequences to IBDC (Indian Biological Data Centre) and GISAID, a global open-access database. The NIV is also in the process of isolating newer variants, he said. "This effort will be helpful to assess vaccine effectiveness and to support India's indigenous efforts for vaccine development," Kumar said. Notably, two monovalent Omicron-based vaccines are available (Biological E Limited's Corbivax and Serum Institute of India's COVOVAX) in the country. On whether there are any requirements for vaccines to tackle the newer variants, Kumar stated that the decision lies with the government. "The decision of whether or not to have a new vaccine using the currently circulating stain is a policy decision. NIV's role is to monitor the recently circulating virus strain," Kumar said, adding that the situation is being continuously monitored by Health Ministry.


Time of India
an hour ago
- Time of India
New Covid variant 'Nimbus' symptoms: 'Painful' health issues to watch out for
A new Covid-19 variant, called NB.1.8.1 , is spreading in several parts of the world, including the United States and Asia. Informally known as "Nimbus", the variant is said to be more transmissible but not necessarily more dangerous than previous strains. What Is the Main Symptom? One of the most talked-about symptoms of the Nimbus variant is a very painful sore throat , often called " razor blade throat ". People have described the feeling as similar to swallowing glass or razor blades. Reports suggest this symptom is becoming more common in those infected with this strain. What Are Other Symptoms? Along with the sore throat, patients infected with the new variant have also reported: Nasal congestion or a runny nose Fatigue Mild cough Fever Muscle or body aches Some people may also experience: Headaches Diarrhoea Nausea or vomiting Loss of taste or smell (less common now) Shortness of breath How Is It Different? Doctors say that the main difference with this variant is the severity of the sore throat. While past variants also caused throat pain, this one seems to cause more intense discomfort. The sore throat comes from irritation caused by infection in the throat's cells. However, many experts believe the overall set of symptoms still matches those of previous Covid-19 strains. Live Events Should You Be Worried? So far, there is no strong evidence that Nimbus leads to more serious illness. But those who are unvaccinated or immunocompromised might still face higher risks, especially for breathing problems. Inputs from agencies